Prevalence of Cryptococcal Antigenemia and Cost-Effectiveness of a Cryptococcal Antigen Screening Program - Vietnam

Rachel M. Smith, Tuan Anh Nguyen, Hoang Thi Thanh Ha, Pham Hong Thang, Cao Thuy, Truong Xuan Lien, Hien T. Bui, Thai Hung Le, Bruce Struminger, Michelle S. McConnell, Robyn Neblett Fanfair, Benjamin J. Park, Julie R. Harris

Research output: Contribution to journalArticle

Abstract

Background:An estimated 120,000 HIV-associated cryptococcal meningitis (CM) cases occur each year in South and Southeast Asia; early treatment may improve outcomes. The World Health Organization (WHO) recently recommended screening HIV-infected adults with CD4<100 cells/mm3 for serum cryptococcal antigen (CrAg), a marker of early cryptococcal infection, in areas of high CrAg prevalence. We evaluated CrAg prevalence and cost-effectiveness of this screening strategy in HIV-infected adults in northern and southern Vietnam.Methods:Serum samples were collected and stored during 2009-2012 in Hanoi and Ho Chi Minh City, Vietnam, from HIV-infected, ART-naïve patients presenting to care in 12 clinics. All specimens from patients with CD4<100 cells/mm3 were tested using the CrAg lateral flow assay. We obtained cost estimates from laboratory staff, clinicians and hospital administrators in Vietnam, and evaluated cost-effectiveness using WHO guidelines.Results:Sera from 226 patients [104 (46%) from North Vietnam and 122 (54%) from the South] with CD4<100 cells/mm3 were available for CrAg testing. Median CD4 count was 40 (range 0-99) cells/mm3. Nine (4%; 95% CI 2-7%) specimens were CrAg-positive. CrAg prevalence was higher in South Vietnam (6%; 95% CI 3-11%) than in North Vietnam (2%; 95% CI 0-6%) (p = 0.18). Cost per life-year gained under a screening scenario was $190, $137, and $119 at CrAg prevalences of 2%, 4% and 6%, respectively.Conclusion:CrAg prevalence was higher in southern compared with northern Vietnam; however, CrAg screening would be considered cost-effective by WHO criteria in both regions. Public health officials in Vietnam should consider adding cryptococcal screening to existing national guidelines for HIV/AIDS care.

Original languageEnglish (US)
Article numbere62213
JournalPloS one
Volume8
Issue number4
DOIs
StatePublished - Apr 23 2013

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Fingerprint Dive into the research topics of 'Prevalence of Cryptococcal Antigenemia and Cost-Effectiveness of a Cryptococcal Antigen Screening Program - Vietnam'. Together they form a unique fingerprint.

  • Cite this

    Smith, R. M., Nguyen, T. A., Ha, H. T. T., Thang, P. H., Thuy, C., Xuan Lien, T., Bui, H. T., Le, T. H., Struminger, B., McConnell, M. S., Fanfair, R. N., Park, B. J., & Harris, J. R. (2013). Prevalence of Cryptococcal Antigenemia and Cost-Effectiveness of a Cryptococcal Antigen Screening Program - Vietnam. PloS one, 8(4), [e62213]. https://doi.org/10.1371/journal.pone.0062213